EP Patent

EP3634430B1 — Multibiotic agents and methods of using the same

Assigned to Flagship Pioneering Innovations V Inc · Expires 2024-08-07 · 2y expired

What this patent protects

Patent listed against rezafungin-acetate.

Drugs covered by this patent

rezafungin-acetate (REZAFUNGIN ACETATE)

Patent Metadata

Patent number: EP3634430B1
Jurisdiction: EP
Classification: —
Expires: 2024-08-07
Drug substance claim: No
Drug product claim: No
Assignee: Flagship Pioneering Innovations V Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.